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SUMMARY AT A GLANCE 
 
The present study documented that additional healthcare visits and rehospitalizations are 
common, with 34% of patients with CAP doing so within 30 days of discharge. This is 
mainly due to a worsening of signs or symptoms of CAP and/or comorbid conditions. 
These findings may have implications for discharge planning and follow-up of patients 
with CAP. 
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ABSTRACT 
Background and objective: We aimed to identify the frequency of, reasons for and 
risk factors associated with additional healthcare visits and rehospitalizations 
(healthcare interactions) by patients with community-acquired pneumonia (CAP) 
within 30 days of hospital discharge.  
Methods: Observational analysis of a prospective cohort of adults hospitalized with 
CAP at a tertiary hospital (2007-2009). Additional healthcare interactions were 
defined as the visits to a primary care centre or emergency department and 
hospital readmissions within 30 days of discharge.  
Results: Of the 934 hospitalized patients with CAP, 282 (34.1%) had additional 
healthcare interactions within 30 days of hospital discharge: 149 (52.8%) needed 
an additional visit to their primary care centre and 177 (62.8%) attended the 
emergency department. Seventy-two (25.5%) patients were readmitted to hospital. 
The main reasons for additional healthcare interactions were worsening of signs or 
symptoms of CAP and new or worsening comorbid conditions independent of 
pneumonia, mainly cardiovascular and pulmonary diseases. The only independent 
factor associated with visits to primary care centre or emergency department was 
alcohol abuse (odds ratio [OR] = 1.65; 95% confidence interval [CI]: 1.03-2.64). 
Prior hospitalization (≤ 90 days) (OR = 2.47; 95% CI: 1.11-5.52) and comorbidities 
(OR = 3.99; 95% CI: 1.12-14.23) were independently associated with 
rehospitalization.  
Conclusions: Additional healthcare visits and rehospitalizations within 30 days of 
hospital discharge are common in patients with CAP. This is mainly due to a 
worsening of signs or symptoms of CAP and/or comorbid conditions. These 
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findings may have implications for discharge planning and follow-up of patients 
with CAP.  
 
Key words: health services, patient discharge, patient readmission, pneumonia, risk 
factors. 
 
Short title: Health services use after CAP discharge 
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INTRODUCTION 
 
Community-acquired pneumonia (CAP) continues to be a major health problem 
worldwide. It is the leading cause of mortality among infectious diseases. In addition, 
CAP accounts for more than 1 million hospitalizations annually, at a cost exceeding 
$9.7 billion.1,2 The high cost of treating CAP has raised interest in developing strategies 
to reduce the length of hospital stay and increase the number of patients who receive 
care at home.3-5  
However, one qualitative study6 found that most patients left hospital with no 
clear understanding of pneumonia, its treatment or follow-up when they got home, 
leading to an increase in primary care centre and emergency visits, cost-ineffective use 
of inpatient beds and lower patient satisfaction.7,8 Despite this, only a few studies have 
examined the frequency of and factors associated with hospital readmission following 
an initial CAP-related hospitalization.1,9-11. Significantly, no studies have examined 
other additional healthcare interactions (primary care centre visits because of doubts or 
complications related to CAP and emergency department visits) within 30 days of 
discharge in patients with CAP.  
A further point is that the strategies to reduce the length of hospital stay and the 
trend towards community-based treatment of CAP needs to be accompanied by 
increased emphasis on the information and support required by patients who go home to 
self-manage.6 Identifying the reasons for and risk factors associated with additional 
healthcare visits and rehospitalizations may therefore be useful in terms of discharge 
planning. Indeed, discharge planning has been associated with improved referral and 
utilization of post-discharge services, as well as with fewer readmissions.12-14 In 
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addition, such planning appears to make patients and caregivers feel more prepared for 
post-discharge care.15,16  
 The present study aimed to identify the frequency of, reasons for and risk factors 
associated with additional healthcare visits and rehospitalizations in patients with CAP 
within 30 days of hospital discharge.   
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METHODS 
 
Setting and study design 
 
The study was carried out in a 900-bed university hospital for adults in Barcelona, 
Spain, one which serves an area of 1,100,000 inhabitants and admits approximately 
24,000 patients per year. All patients with CAP who were admitted to the hospital from 
January 2007 to December 2009 were prospectively recruited and followed up. Patients 
with neutropenia, immunoglobulin deficiencies, HIV infection, transplantation or 
splenectomy, as well as those who were receiving immunosuppressant and/or 
corticosteroid therapy (>20 mg/day of prednisone or its equivalent), were not included.  
For the purposes of this study, patients with CAP were classified into the 
following two groups: those who had additional healthcare interactions (healthcare 
visits and rehospitalizations) within 30 days of hospital discharge and those who did 
not. Patients who died during hospitalization were excluded from this analysis. For the 
inclusion in the group of additional healthcare interactions, patients had to fulfil any of 
the following criteria within 30 days of discharge: 
1. Primary care centre visits because of doubts or complications related to 
CAP (scheduled follow-up visits were excluded). 
2. Emergency department visits for any reason. 
3. Hospital readmission for any reason. 
We collected the first episode and the main reasons of additional healthcare 
visits and rehospitalizations within 30 days of discharge. This prospective, 
observational study was approved by the institutional review board and informed 
consent was obtained from patients.  
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Clinical evaluation and follow-up 
 
Patients were seen daily during their hospital stay by one or more of the research team, 
who recorded clinical data in a computer-assisted protocol. Data were collected on 
demographic characteristics, comorbidities, causative organisms, empirical antibiotic 
therapy and outcomes, including in-hospital mortality. Data about additional healthcare 
interactions within 30 days of discharge were obtained by reviewing the SAP 
Healthcare Database of the Catalan Health Service (Institut Català de la Salut). 
 Severity of illness at presentation was quantified using the Pneumonia Severity 
Index (PSI).17 Clinical stability was considered as described elsewhere.18 Healthcare-
associated pneumonia (HCAP) was defined as patients who received intravenous 
therapy at home, attended a hospital or haemodialysis clinic in the 30 days prior to onset 
of pneumonia, were admitted to an acute hospital in the 90 days before pneumonia 
onset, or who resided in a nursing home or long-term care facility.19 
 
Reasons for additional healthcare visits and rehospitalizations 
   
In order to assign the reasons for visits to primary care centres, rehospitalization or 
emergency department visits within 30 days of the initial hospitalization, three research 
nurses (J.A., P.C. and O.C.) and one physician (D.V.) reviewed the visit-to-primary care 
reports and the emergency, hospital admission and discharge reports of patients. For all 
cases, the reasons for the use of resources were agreed by all investigators consensus 
after reviewing the clinical data. Visits to a primary care centre were defined as 
consultations because of doubts or complications related to CAP within 30 days of 
discharge. These were categorized into seven groups: 1) respiratory symptoms; 2) 
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doubts about medical prescription drugs or adverse drug effects; 3) general symptoms; 
4) cognitive impairment; 5) fever; 6) gastrointestinal symptoms; and 7) underlying 
disease exacerbation. The reasons for emergency department visits or readmission were 
categorized as described elsewhere1: 1) pneumonia-related worsening of signs or 
symptoms; 2) new or worsening comorbid conditions independent of pneumonia; or 3) 
any combination of pneumonia-related and comorbidity-related reasons. Patients were 
defined as having a pneumonia-related rehospitalization if a chest radiograph showed an 
infiltrate and if ≥3 typical or atypical symptoms of pneumonia were present. If there 
was insufficient documentation to establish the presence of a radiographic infiltrate at 
the time of hospital readmission, an oxygen saturation <92% and the presence of ≥3 
symptoms was also used to define a pneumonia-related rehospitalization. Patients were 
defined as having a comorbidity-related rehospitalization if clinical data suggested an 
alternative reason for readmission, such as renal failure or heart failure. Finally, patients 
were assigned to any combination of pneumonia-related and comorbidity-related 
reasons if the primary reason for readmission could not be accurately determined, such 
as in the case of exacerbation of chronic lung disease.  
 
Statistical analysis 
 
Significant differences between groups were detected using the chi-square test for 
categorical variables. For continuous variables we used the Student’s t-test or Mann-
Whitney U test, depending on the results of the Kolmogorov-Smirnov normality test. 
The logistic-regression model of factors potentially associated with rehospitalizations 
and additional visits to primary care centre or visits to emergency department within 30 
days of hospital discharge included all the significant variables in the univariate analysis 
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(if there is a plausible biological relationship to the dependent outcome variable in order 
to avoid spurious associations) and all clinically important variables (sex, age, 
vaccination status, comorbidities, hospitalization within previous 90 days, clinical 
stability at hospital discharge and high-risk PSI classes), regardless of whether the latter 
were significant or not. Independent variables were checked for collinearity. We 
restricted the number of variables included in the multivariable model following the rule 
of at least five to nine events per variable.20 The goodness-of-fit of the model was 
evaluated by the Hosmer-Lomeshow test. Statistical analysis was performed with the 
SPSS software package version 15.0 (SPSS, Chicago, IL). P values less than 0.05 were 
considered statistically significant. All reported p values are 2-tailed. 
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RESULTS 
 
Patient characteristics 
 
During the study period, 934 non-immunosuppressed adults with CAP were 
hospitalized. Of these, 106 (11.3%) died during hospitalization. Of the 828 patients 
discharged from the hospital, 282 (34.1%) had additional healthcare visits and 
rehospitalizations within 30 days of leaving hospital discharge. Among these patients, 
149 (52.8%) visited a primary care centre because of doubts or complications related to 
CAP, while 177 (62.8%) visited the emergency department, of whom 72 were 
readmitted to the hospital (Figure 1).   
The clinical characteristics during hospitalization of patients who had and had 
not additional healthcare interactions are compared in Table 1. Age and the frequency 
of male gender were similar between the groups. Patients who had additional healthcare 
interactions were more likely to be heavy drinkers and more often had been hospitalized 
within the previous 90 days. In addition, they more frequently had received the 
pneumococcal vaccine. Regarding comorbidities, patients who had additional healthcare 
interactions more often had chronic obstructive pulmonary disease (COPD). Similarly, 
patients who had additional healthcare interactions required less frequently ICU 
admission during hospitalization. No significant difference was found between groups 
regarding criteria of clinical stability at hospital discharged. However, tachypnea at 
hospital discharge tended to be associated with additional healthcare interactions. 
Among the causative pathogens of pneumonia, Haemophilus influenzae was 
most frequently identified in patients who had additional healthcare interactions. No 
differences were found between other causative organisms. 
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Reasons for primary care centre visits, emergency department visits or 
readmissions 
 
As shown in Table 2 the main reasons for primary care visits were respiratory and 
general symptoms. Less frequent reasons were gastrointestinal symptoms, cognitive 
impairment and underlying disease exacerbation. The main reasons for emergency 
department visits were pneumonia-related worsening of signs or symptoms and 
comorbid conditions independent of pneumonia. The most frequently identified 
comorbid condition leading to an emergency department visit was cardiovascular 
problems, followed by pulmonary and genitourinary diseases (Table 3). Similarly, the 
main reason for readmissions was new or worsening comorbid conditions independent 
of pneumonia. The main comorbid conditions related to readmission were 
cardiovascular and pulmonary disease and cancer (Table 4).  
 
Risk factors associated with additional healthcare visits and rehospitalizations 
  
Table 5 and 6 summarizes the results of the multivariable analyses of risk factors 
potentially associated with additional visits to primary care centre or emergency 
department and rehospitalizations within 30 days of hospital discharge in patients with 
CAP respectively. After adjustment for confounders, alcohol abuse (odds ratio [OR] = 
1.65; 95% confidence interval [CI]: 1.03-2.64) was found to be independent factor 
associated with additional healthcare visits. Furthermore, prior hospitalization (≤ 90 
days) (OR=2.47; 95% CI: 1.11-5.52) and comorbidities (OR = 3.99; 95% CI: 1.12-
14.23) were associated with hospital readmissions. The p-value of the Hosmer-
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Lemeshow statistics for goodness-of-fit of the two models were was 0.59 and 0.36 
respectively. 
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DISCUSSION 
 
This prospective cohort study found that additional healthcare visits and 
rehospitalizations within 30 days of hospital discharge were common among patients 
with CAP (34.1% of patients). The main reasons for additional healthcare interactions 
were worsening of signs or symptoms of CAP and new or worsening comorbid 
conditions independent of pneumonia. The only independent factor associated with 
additional healthcare visits was alcohol abuse. Prior hospitalization (≤ 90 days) and 
comorbidities were independently associated with hospital readmissions. 
Taking into account that scheduled follow-up visits were excluded, the results 
show that additional healthcare interactions were used by more than one third of 
patients with CAP following hospital discharge. Nearly half of these patients needed an 
additional visit to a primary care centre or attended the emergency department. Studies 
to date have not analysed the frequency of visits to primary care centers and emergency 
departments within 30 days of hospital discharge in patients with CAP. By contrast, 
some studies have examined the frequency of and risk factors for a short-term hospital 
readmission following discharge for a CAP-related hospitalization. In those studies, 
about 7-12% of patients were rehospitalized within 30 days of discharge.1,9,11 A similar 
result was found in the present study (8.7% of patients were readmitted within 30 days 
of discharge).   
Here the main reason for visits to a primary care centre or the emergency 
department after hospital discharge was worsening of respiratory and general symptoms 
related with CAP. We also found that the most common reason for readmission was 
new or worsening comorbid conditions independent of pneumonia, mainly cardiac or 
pulmonary diseases. Our data concur with those of a previous study1 that evaluated 
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reasons for rehospitalization in patients with CAP, and which also found that new or 
worsening cardiac or pulmonary disease was the most frequent cause of readmissions.  
The present results also show that alcohol abuse was the only independent factor 
associated with additional healthcare visits (visits to primary care centre or emergency 
department) after discharge. In this regard, it is well known that the incidence of CAP is 
greater in individuals with a history of alcohol abuse.21 Similarly, alcohol abuse is 
associated with increased morbidity in patients with CAP, resulting in a greater 
incidence of bacteremia, delayed time to recovery, and a higher frequency of persistent 
pulmonary infiltrates on the chest radiograph.22-24 Furthermore, comorbidities were 
associated with hospital readmissions. Previous study also reported that the majority of 
rehospitalizations following pneumonia are comorbidity-related and are the result of 
underlying cardiopulmonary diseases.1 In addition, we found that hospitalization within 
previous 90 days of pneumonia-related episode was independently associated with 
hospital readmissions. This data concurs with others studies in which patients with 
previous hospitalization are at increased risk of rehospitalizations.25  
Moreover, we found that prior pneumococcal vaccination was not independently 
related with a reduced risk of hospital readmissions. Similarly, in a previous population-
based cohort study, prior pneumococcal vaccination did not significantly reduce the risk 
of death or subsequent hospitalization.26 On the other hand, we found that clinical 
instability on hospital discharged was not associated with additional healthcare 
interactions. However, tachypnea tended to be associated with additional healthcare 
interactions in univariate analysis. In addition, it should be noted that it is likely that 
some patients with clinical instability at discharge could have continued hospital-based 
home care. Unfortunately, this information was not collected in this study. 
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In light of the above it should be noted that previous research has shown that 
effective discharge planning can reduce additional healthcare visits and 
rehospitalizations and increase the cost-effective use of inpatient beds and patient 
satisfaction.7,15,27 Discharge planning begins with an early assessment of the anticipated 
patient care needs. In addition, it includes concern for the patient well-being and 
involves the patient, his/her family and caregivers in a dynamic and interactive 
communication. The aim is to reach mutual agreement regarding continuing care.28,29 
Therefore, the ability of physicians and nurses to facilitate an effective discharge 
process has never been more urgent and complex than in the current care context.27,30 
The present study highlights a number of points that should be acknowledged prior to 
discharge planning in CAP patients. According to the results, patients with CAP have, 
upon discharge, specific information needs related to the management of signs or 
symptoms of pneumonia, as well as to underlying comorbid conditions and appropriate 
outpatient follow-up.  
The strengths of this study are its prospective design and the large number of 
patients included. Similarly, there was comprehensive clinical data collection and the 
research was conducted using a standardized protocol. The study is limited by the fact it 
was carried out at a single centre, and also that information about additional healthcare 
interactions was obtained by reviewing the hospital database rather than through patient 
interviews. Nevertheless, there were no missing data about additional healthcare 
interactions and the investigators assessed all the consultations and hospital records. 
Moreover, confounding by indication may explain why prior pneumococcal vaccine 
appeared to increase the risk of the outcomes.  In this regard, if we restricted our 
analysis to patients aged ≥ 65 years, prior pneumococcal vaccination was not related 
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with additional healthcare interactions (P=0.44) in the multivariate logistic regression 
analysis. 
In conclusion, this study shows that additional healthcare visits and 
rehospitalizations within 30 days of hospital discharge are common in patients with 
CAP. These additional healthcare interactions are mainly due to worsening of signs or 
symptoms of CAP and to new or worsening comorbid conditions independent of 
pneumonia. After adjustment, the only risk factor associated with additional healthcare 
visits was alcohol abuse. Prior hospitalization (≤ 90 days) and comorbidities were 
independently associated with hospital readmissions. Our findings may have 
implications for discharge planning and follow-up of patients with CAP.  
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Table 1 Main clinical characteristics of patients hospitalized for community-acquired pneumonia according to additional 
healthcare interactions. 
Additional healthcare 
interactions (n=282) 
Non additional healthcare 
interactions (n=546) 
Characteristic N  (%) N  (%) 
P-value 
Age, median (IQR), years 72  (58-80) 71 (55-79) 0.33 
Demographic characteristics  
Male gender 193 (68.4) 352 (64.5) 0.25 
Current smoker  78 (27.8) 135 (24.8) 0.35 
Heavy drinker 55 (19.6) 68 (12.5) 0.007 
Influenza vaccine (<1year) 154 (61.4) 265 (54.1) 0.06 
Pneumococcal vaccine (<5years) 71 (31.7) 97 (21.3) 0.003 
Previous CAP (<1year) 31 (11.2) 56 (10.3) 0.69 
HCAP 90 (31.9) 141 (25.8) 0.06 
Nursing home resident 17 (6) 49 (9) 0.14 
Hospitalization within previous 90 days 35 (12.4) 36 (6.6) 0.005 
Underlying disease 221 (78.4) 400 (73.4) 0.12 
COPD 92 (32.6) 131 (24) 0.008 
Diabetes mellitus 71 (25.2) 148 (27.1) 0.55 
Chronic heart disease 60 (21.3) 94 (17.2) 0.15 
Cancer 28 (9.9) 49 (9) 0.65 
Cerebrovascular disease 41 (14.5) 67 (12.3) 0.36 
Dementia 17 (6) 24 (4.4) 0.30 
Chronic liver disease  18 (6.4) 28 (5.1) 0.45 
Chronic renal disease 33 (11.7) 43 (7.9) 0.07 
High-risk PSI classes* 185 (65.6) 330 (60.4) 0.15 
Clinical findings at admission  
Shock  27 (9.6) 53 (9.7) 0.95 
Altered mental status  47 (16.7) 89 (16.3) 0.89 
Purulent sputum 146 (51.8) 216 (39.8) 0.001 
Pleuritic chest pain 101 (35.8) 220 (40.4) 0.19 
Physical examination findings 
Axillary temperature on admission, 37.5 (36.9-38) 37.7 (37-38.2) 0.14 
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median (IQR), ºC 
Fever (>37.2 ºC) 184 (65.5) 372 (68.8) 0.34 
Rales 242 (86.1) 454 (83.8) 0.37 
Laboratory and radiographic findings 
SatO2<90 or PO2/FiO2†<300 169 (64) 324 (63.5) 0.89 
Bacteremia 30 (12.6) 49 (10.3) 0.36 
Multilobar pneumonia 83 (29.5) 181 (33.3) 0.27 
Pleural effusion  45 (16)   89 (16.3) 0.89 
Complications during hospitalization‡ 69 (24.5) 152 (27.8) 0.32 
Adverse event during hospitalization§ 38 (13.5) 78 (14.3) 0.75 
ICU admission 17 (6) 55 (10.1) 0.05 
Mechanical ventilation 7 (2.5) 31 (5.7) 0.04 
Clinical stability on hospital discharge¶ 230 (92.3) 484 (92.7) 0.81 
      Tachypnea 14 (5.2) 14 (2.7) 0.08 
      O2 Saturation < 90% 7 (2.6) 19 (3.7) 0.42 
Aetiology 
Streptococcus pneumonia 127 (45) 246 (45.1) 0.99 
Legionella pneumophila 5 (1.8) 20 (3.7) 0.13 
Haemophilus influenzae 23 (8.2) 14 (2.6) <0.001 
Anaerobic organism  12 (4.3) 35 (6.4) 0.20 
Duration of first hospitalization, median 
(IQR), days 
7 (5-11) 7 (5-11) 0.73 
Abbreviations: HCAP, healthcare-associated pneumonia; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; IQR, 
interquartile range. 
* Patients were stratified into high-risk classes according to the PSI score (>90 points, classes IV and V). 
† Partial pressure of oxygen in arterial blood (PO2) and the fraction of inspired oxygen (FiO2). 
‡ Related to the disease. 
§
 Related to pharmacological treatment.  
 ¶ Clinical stability as described by Halm.5 
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Table 2 Reasons for visits to a primary care centre within 30 days of hospital discharge in 149 patients*. 
Reason N  (%) 
Respiratory symptoms 112 (75.2) 
General symptoms 34 (22.8) 
Fever 13 (8.7) 
Doubts about medical prescription drugs or adverse drug effects 7 (4.7) 
Gastrointestinal symptoms 6 (4) 
Cognitive impairment 3 (2) 
Underlying disease exacerbation 3 (2) 
* 29 patients reported >1 reason to primary care centre 
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Table 3 Reasons for emergency department visits within 30 days of hospital discharge in 177 patients. 
Reason N  (%) 
Pneumonia-related worsening of signs or symptoms 84 (47.5) 
New or worsening comorbid conditions independent of pneumonia 77 (43.5) 
Cardiovascular 20 (11.3) 
Pulmonary (unrelated to pneumonia) 11 (6.2) 
Genitourinary 8 (4.5) 
Other* 8 (4.5) 
      Gastrointestinal 6 (3.4) 
Neurological 5 (2.8) 
Orthopaedic 5 (2.8) 
Neoplastic 5 (2.8) 
Infection 5 (2.8) 
Adverse drug effects 4 (2.3) 
Any combination of pneumonia-related and comorbidity-related reasons† 16 (9) 
* 
 For patients who visited the emergency department for new or worsening comorbid conditions independent of 
pneumonia, other comorbid conditions were as follows: hyperglycaemia (n=1), retinal detachment (n=1), eye cataract 
(n=1), insect bite (n=1), vasovagal syncope (n=1), hepatic encephalopathy (n=1), epistaxis (n=1) and tracheal 
granuloma (n=1). 
†
 For patients who visited the emergency department for both pneumonia and comorbidity-related reasons, the 
comorbid conditions were exacerbation of chronic pulmonary disease or aspiration.  
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Table 4 Reasons for readmission within 30 days of hospital discharge in 72 patients. 
Reason N  (%) 
New or worsening comorbid conditions independent of pneumonia 31 (43.1) 
Cardiovascular 12 (16.7) 
Pulmonary (unrelated to pneumonia) 8 (11.1) 
Neoplastic 5 (6.9) 
Infection 2 (2.8) 
Neurological 1 (1.4) 
      Gastrointestinal 1 (1.4) 
Adverse drug effects 1 (1.4) 
Retinal detachment 1 (1.4) 
Pneumonia-related worsening of signs or symptoms 28 (38.9) 
Any combination of pneumonia-related and comorbidity-related reasons* 13 (18.1) 
*
 For patients who visited the emergency department for both pneumonia and comorbidity-related reasons, the comorbid 
conditions were exacerbation of chronic pulmonary disease or aspiration. 
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Table 5 Factors associated with additional visits to a primary care centre or visits to emergency department within 30 days 
of discharge: multivariate analysis. 
Characteristic Odds Ratio 95% Confidence Interval P-value 
Aged ≥ 65 years 0.82 0.52-1.29 0.40 
Male gender 0.76 0.52-1.11 0.16 
Alcohol abuse 1.65 1.03-2.64 0.04 
Pneumococcal vaccine (<5 years) 1.18 0.76-1.84 0.46 
Influenza vaccine (<1 year) 1.06 0.68-1.64 0.80 
Prior hospitalization (≤ 90 days) 1.39 0.76-2.54 0.29 
Comorbidities* 0.99 0.62-1.59 0.97 
High-risk PSI classes† 1.19 0.78-1.83 0.42 
Clinical stability on discharge 0.85 0.45-1.62 0.62 
Abbreviations: ICU, intensive care unit. 
* Comorbidities includes: chronic obstructive pulmonary disease, diabetes mellitus, chronic heart disease, cancer, cerebrovascular 
disease, dementia, chronic liver disease and chronic renal disease.  
† Patients were stratified into high-risk classes according to the PSI score (>90 points, classes IV and V). 
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Table 6 Factors associated with hospital readmission within 30 days of discharge: multivariate analysis. 
Characteristic Odds Ratio 95% Confidence Interval P-value 
Aged ≥ 65 1.43 0.66-3.01 0.37 
Male gender 1.58 0.77-3.21 0.21 
Pneumococcal vaccine (<5 years) 1.83 0.92-3.63 0.08 
Influenza vaccine (<1 year) 1.16 0.53-2.55 0.71 
Prior hospitalization (≤ 90 days) 2.47 1.11-5.52 0.03 
Comorbidities* 3.99 1.12-14.23 0.03 
High-risk PSI classes† 0.65 0.32-1.31 0.22 
Clinical stability on discharge 1.80 0.41-7.93 0.44 
Haemophilus influenzae pneumonia 1.70 0.59-4.88 0.32 
* Comorbidities includes: chronic obstructive pulmonary disease, diabetes mellitus, chronic heart disease, cancer, 
cerebrovascular disease, dementia, chronic liver disease and chronic renal disease. 
† Patients were stratified into high-risk classes according to the PSI score (>90 points, classes IV and V). 
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Figure 1 Additional healthcare visits and rehospitalizations after hospital discharge in 
community-acquired pneumonia 
 
* After 30 days of hospital discharge. 
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* After 30 days of hospital discharge.  
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